Thursday, June 12, 2025

Italian Hospitals Could Boost HIV Detection with Universal Opt-Out Testing

Similar articles

Italy faces a critical challenge with thousands living undiagnosed with HIV, prompting researchers to explore more effective testing strategies within emergency departments.

Evaluating Testing Approaches

A comprehensive study utilized a closed-cohort hybrid decision tree-Markov model to assess the economic and health benefits of two HIV testing methods in Italian emergency departments: the traditional indicator-condition-guided (IC) testing and a universal opt-out testing strategy. Data were meticulously gathered from national healthcare reports and published studies, focusing on life years, quality-adjusted life years (QALYs), and associated costs from the National Health Service perspective over a lifetime horizon.

Subscribe to our newsletter

Impact on Health Outcomes and Costs

The findings revealed that universal opt-out testing leads to better health outcomes, identifying approximately 15.78 more new HIV cases and linking 14.47 additional individuals to care per 10,000 emergency department visitors compared to the IC approach. Although this method incurs higher initial costs, it becomes cost-effective when HIV prevalence exceeds 0.25%, based on a willingness-to-pay threshold of €30,000 per QALY.

Inferences:

  • Universal opt-out testing significantly increases the detection of undiagnosed HIV cases.
  • The economic viability of opt-out testing improves with higher HIV prevalence rates.
  • Enhanced linkage to care through opt-out strategies may reduce long-term healthcare burdens.

The study highlights universal opt-out HIV testing as a promising strategy to enhance early detection and improve patient outcomes in Italy’s healthcare system. By surpassing the current IC-guided testing, this approach could play a pivotal role in managing the HIV epidemic more effectively.

Implementing universal opt-out testing requires strategic policy adjustments and resource allocation. However, the potential benefits in increased diagnoses and better linkage to care present a strong case for its adoption. Further research incorporating real-world data is essential to validate these results and optimize the implementation process. For healthcare policymakers, prioritizing regions with higher HIV prevalence for opt-out testing initiatives could maximize both health benefits and economic efficiency, ultimately contributing to a more robust public health framework in Italy.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article